NDC 82922-019 - Truemed Group LLC
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 82922-019
- Package NDCs from labels
- 82922-019-01
- Manufacturer
- Truemed Group LLC
- Effective date
- 2022-08-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| IRBESARTAN-HYDROCHLOROTHIAZIDE - Truemed Group LLC | Truemed Group LLC | 2022-08-10 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 9492a1cd-c012-4b43-931d-235220065e1e | 2023-01-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH J0E2756Z7N |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 3b80f726-9e1e-4d44-ad4f-afd10e26292f | 2023-01-27 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 5b476740-e3f0-4f68-b07c-cd9eb2fa27ca | 2023-01-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 8c65d555-8db8-40d9-be30-309ef09f19be | 2023-01-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Metoprolol Tartrate and Hydrochlorothiazide | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 538ea34a-1ac3-48c8-b841-43be09285e12 | 2023-01-17 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | 15e6f934-fe66-4640-bdf1-13b389cd9e54 | 2023-01-04 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 189ad040-07e9-42a5-854c-67633367da74 | 2023-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Amiloride Hydrochloride and Hydrochlorothiazide | AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | Teva Pharmaceuticals USA, Inc. | 8b2c581a-f955-4a8e-bf85-e768e903fd10 | 2022-12-27 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| ed8b2c7a-0798-47f6-e053-2995a90afbb2 | e5e5c72d-9589-1c0a-e053-2a95a90aff0f | 2022-11-15 | e5e5c72d-9589-1c0a-e053-2a95a90aff0f | |||
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Zydus Lifesciences Limited | 35ed3030-a9b3-4e4e-99cd-6d5c31ad22fa | 2022-11-07 | 0J48LPH2TH | |
| valsartan and hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Zydus Lifesciences Limited | bd199010-1d85-4011-939c-4704ecfaba1f | 2022-11-05 | 0J48LPH2TH | |
| losartan potassium and hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | 35099fd1-1bc9-428b-9b9c-71f574cc4156 | 2022-11-03 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Macleods Pharmaceuticals Limited | 771afba6-8769-4ea8-afec-358dba0aaefe | 2022-11-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan | IRBESARTAN | Proficient Rx LP | f0ec2ccc-7d79-4cde-a13e-08faeea4e934 | 2022-07-01 | Boxed warning, Warnings, Adverse reactions | J0E2756Z7N |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | a9098fc6-3d2a-404f-a4cd-2e181ebbd626 | 2022-07-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| IRBESARTAN | IRBESARTAN | Alembic Pharmaceuticals Limited | 0898f423-0aa9-409c-8d4e-1349b59141d1 | 2022-06-03 | Boxed warning, Warnings, Adverse reactions | J0E2756Z7N |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | 98edae8a-99dc-4f26-a956-3ad58bf38a26 | 2022-06-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | af0b3bef-be36-432a-884e-ea81e2d5c08e | 2022-06-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | 48b4d633-ecfa-4748-80e8-6c0e3d8b067e | 2022-05-02 | Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan | IRBESARTAN | Proficient Rx LP | 950e33da-5e77-40df-b73b-dd084b36a804 | 2022-05-02 | Boxed warning, Warnings, Adverse reactions | J0E2756Z7N |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.